• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4: Owl Creek Asset Management, L.P. disposed of $5,175,450 worth of shares (465,000 units at $11.13)

    8/21/23 6:18:49 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $DKDCA alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
    X
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Owl Creek Asset Management, L.P.

    (Last) (First) (Middle)
    640 FIFTH AVENUE
    20TH FLOOR

    (Street)
    NEW YORK NY 10019

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Data Knights Acquisition Corp. [ DKDCA ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    08/11/2023
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock, par value $0.0001 per share 08/11/2023 J(1) 465,000 D $11.13 0 I See footnote(2)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    1. Name and Address of Reporting Person*
    Owl Creek Asset Management, L.P.

    (Last) (First) (Middle)
    640 FIFTH AVENUE
    20TH FLOOR

    (Street)
    NEW YORK NY 10019

    (City) (State) (Zip)
    1. Name and Address of Reporting Person*
    ALTMAN JEFFREY A

    (Last) (First) (Middle)
    640 FIFTH AVENUE, 20TH FLOOR

    (Street)
    NEW YORK NY 10019

    (City) (State) (Zip)
    Explanation of Responses:
    1. The Reporting Persons elected to redeem 465,000 shares held by OCCOMF (as defined below) for cash.
    2. The securities to which this filing relates are held directly by Owl Creek Credit Opportunities Master Fund, L.P. ("OCCOMF"), a Cayman Islands exempted limited partnership, to which Owl Creek Asset Management, L.P., a Delaware limited partnership (the "Investment Manager"), serves as investment manager. Jeffrey A. Altman ("Mr. Altman") is the managing member of the general partner of the Investment Manager. Each of the Investment Manager and Mr. Altman disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.
    Owl Creek Asset Management, L.P. By: /s/ Owl Creek GP, L.L.C., its general partner By: /s/ Jeffrey A. Altman, Managing Member 08/21/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $DKDCA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DKDCA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DKDCA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Casey Paul claimed ownership of 599,172 shares (SEC Form 3)

      3 - OneMedNet Corp (0001849380) (Issuer)

      11/15/23 4:18:48 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • New insider Kosasa Thomas claimed ownership of 4,952,409 shares (SEC Form 3)

      3 - OneMedNet Corp (0001849380) (Issuer)

      11/15/23 2:08:21 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form 4: Owl Creek Asset Management, L.P. disposed of $5,175,450 worth of shares (465,000 units at $11.13)

      4 - Data Knights Acquisition Corp. (0001849380) (Issuer)

      8/21/23 6:18:49 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $DKDCA
    SEC Filings

    See more
    • Data Knights Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - OneMedNet Corp (0001849380) (Filer)

      2/9/24 4:15:31 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form S-1 filed by Data Knights Acquisition Corp.

      S-1 - OneMedNet Corp (0001849380) (Filer)

      12/18/23 8:29:14 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Data Knights Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - OneMedNet Corp (0001849380) (Filer)

      11/22/23 5:30:12 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $DKDCA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • OneMedNet Network Expands with New Partnership with Large Academic Research Medical Center to Benefit its Life Science Company Clients

      ~ Partnership To Leverage Real World Data for Life Science Innovation Accelerating New Diagnostic and Treatment Solutions ~MINNEAPOLIS, MN / ACCESSWIRE / November 9, 2023 / OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet"), the leading curator of regulatory-grade imaging Real World Data ("RWD"), today announced a new partnership with a leading research medical center to accelerate and expand development of new diagnostic and treatment solutions using OneMedNet's iRWD™. Life Science innovators, including pharmaceutical, AI, medical device, and clinical research organizations, are now able to effectively use existing real world data for discovery, development, regulatory-approval, and post-mar

      11/9/23 4:15:00 PM ET
      $DKDCA
      $ONMD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • OneMedNet Completes Business Combination with Data Knights Acquisition Corp. to Become a Publicly Traded Company

      OneMedNet Common Stock to Trade on Nasdaq Under Ticker "ONMD" Tomorrow, Wednesday, November 8, 2023OneMedNet to Fully Embark on its Growth Strategy as it Spearheads the Imaging RWD Solution in the $400 Billion Clinical MarketMINNEAPOLIS, MN / ACCESSWIRE / November 7, 2023 / OneMedNet Corporation (NASDAQ:DKDCA)(NASDAQ:DKDCW) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Imaging Real World Data ("RWD"), through its proven OneMedNet iRWD™ solution, today announced that it has completed its previously announced business combination with Data Knights Acquisition Corp. ("Data Knights"). The business combination was approved at a special meeting of Data Knights' stockholde

      11/7/23 2:00:00 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Data Knights Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination

      MINNEAPOLIS, MN and LONDON, UK / ACCESSWIRE / October 12, 2023 / Data Knights Acquisition Corp. ("Data Knights" or the "Company") (NASDAQ:DKDCU, DKDCA, DKDCW))), a special purpose acquisition company, today announced that on October 10, 2023 it caused to be deposited $75,000 into the Company's trust account, allowing the Company to extend the period of time it has to consummate its initial business combination by one month from October 11, 2023 to November 11, 2023 (the "Extension"). The Extension is the third of nine (9) one-month extensions permitted under the Company's governing documents. Cautionary Statement Regarding Forward-Looking StatementsThis press release contains statements

      10/12/23 4:45:00 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $DKDCA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Data Knights Acquisition Corp. (Amendment)

      SC 13G/A - OneMedNet Corp (0001849380) (Subject)

      2/14/24 6:03:43 AM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form SC 13G/A filed by Data Knights Acquisition Corp. (Amendment)

      SC 13G/A - OneMedNet Corp (0001849380) (Subject)

      2/5/24 1:55:23 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form SC 13G filed by Data Knights Acquisition Corp.

      SC 13G - Data Knights Acquisition Corp. (0001849380) (Subject)

      4/11/23 12:00:45 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $DKDCA
    Leadership Updates

    Live Leadership Updates

    See more
    • OneMedNet Appoints Healthcare IT Executive, Aaron Green, as President

      ~ Signaling a New Chapter of Growth for the Innovative Solution of Real World Data~MINNEAPOLIS, MN / ACCESSWIRE / May 23, 2023 / OneMedNet Corporation ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Imaging Real Word Data, through its proven OneMedNet iRWD™ solution, today announced the expansion of its executive team with the appointment of healthcare technology veteran, Aaron Green, as President. In this new role, Green will be responsible for all the major growth functions and lead engagement with existing clients, new clients, sales operations, marketing, communications, and product innovation, reporting directly to the CEO.Green is a healthcare technology busines

      5/23/23 4:05:00 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care